Robert Gut
CIK 1716268 · Chief Medical Officer · last filed 2026-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.28M
Companies
2
Total Filings
33
Lifetime Open-Market Net
-$4.96M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| QURE | Director | 32,342 | $39.71 | $1.28M | -$4.96M | 26 | 2026-06-12 |
| Aravive, Inc. (VSAR) Delisted | Chief Medical Officer | 37,883 | — | — | $0 | 3 | 2017-12-22 |
Recent Filings · Page 2 of 4
33 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-17 | QURE | Sell (S) | −3,504 | -$17.9K | EDGAR |
| 2023-06-20 | QURE | Mixed | +5,472 | -$60.9K | EDGAR |
| 2023-03-01 | QURE | Sell (S) | −1,968 | -$40.9K | EDGAR |
| 2022-06-17 | QURE | Grant (A) | +9,080 | $0 | EDGAR |
| 2022-03-02 | QURE | Sell (S) | −1,602 | -$26.8K | EDGAR |
| 2022-02-28 | QURE | Grant (A) | +1,534 | $0 | EDGAR |
| 2022-01-28 | QURE | Sell (S) | −2,348 | -$42.5K | EDGAR |
| 2021-09-22 | QURE | Sell (S) | −4,500 | -$164.7K | EDGAR |
| 2021-03-04 | QURE | Sell (S) | −1,300 | -$48.1K | EDGAR |
| 2021-03-01 | QURE | Grant (A) | +2,382 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.